Literature DB >> 13991207

Long-term anti-coagulation in sickle-cell disease. A clinical study.

J E SALVAGGIO, C A ARNOLD, C H BANOV.   

Abstract

Keywords:  ANEMIA, SICKLE CELL; WARFARIN

Mesh:

Substances:

Year:  1963        PMID: 13991207     DOI: 10.1056/NEJM196307252690403

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

Review 1.  Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.

Authors:  Marilyn J Telen
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

Review 2.  Redox-dependent impairment of vascular function in sickle cell disease.

Authors:  Mutay Aslan; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2007-08-31       Impact factor: 7.376

Review 3.  Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.

Authors:  Junaid Ansari; Youmna E Moufarrej; Rafal Pawlinski; Felicity N E Gavins
Journal:  Expert Rev Hematol       Date:  2017-12-05       Impact factor: 2.929

4.  Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease.

Authors:  Erica M Sparkenbaugh; Pichika Chantrathammachart; Jacqueline Mickelson; Joanne van Ryn; Robert P Hebbel; Dougald M Monroe; Nigel Mackman; Nigel S Key; Rafal Pawlinski
Journal:  Blood       Date:  2014-01-21       Impact factor: 22.113

5.  Anticoagulants in sickle cell disease.

Authors:  A D Klinger; A Perez
Journal:  J Natl Med Assoc       Date:  1972-05       Impact factor: 1.798

6.  Role of the coagulation system in the pathogenesis of sickle cell disease.

Authors:  Md Nasimuzzaman; Punam Malik
Journal:  Blood Adv       Date:  2019-10-22

Review 7.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

8.  Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.

Authors:  Paritha I Arumugam; Eric S Mullins; Shiva Kumar Shanmukhappa; Brett P Monia; Anastacia Loberg; Maureen A Shaw; Tilat Rizvi; Janaka Wansapura; Jay L Degen; Punam Malik
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113

Review 9.  Interplay between coagulation and vascular inflammation in sickle cell disease.

Authors:  Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

10.  Coagulation fibrinolysis in sickle-cell disease.

Authors:  P A Gordon; G R Breeze; J R Mann; J Stuart
Journal:  J Clin Pathol       Date:  1974-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.